why choose us

First received: January 09, 2023

Clinical Trial: A Study of TAK-861 in Participants With Narcolepsy Type 2

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Narcolepsy Type 2

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-861 for the Treatment of Narcolepsy Without Cataplexy (Narcolepsy Type 2)

Brief Summary: The main aim is to evaluate the effect of TAK-861 on symptoms of narcolepsy, including excessive daytime sleepiness (EDS) as measured by sleep latency from the Maintenance of Wakefulness Test (MWT).The study will enroll approximately 60 participants and they will be randomly assigned to 3 groups (20 per group) to take one of two different doses of TAK-861 or a placebo.All the participants will receive the treatment for 8 weeks.Participants will be asked to complete some questionnaires during the study.This trial…

Read more